Michael D Wilson Selected Research

Michael D Wilson Research Topics

Disease

14	Malaria 07/2022 - 08/2005
10	Infections 07/2022 - 04/2008
5	Hookworm Infections (Hookworm Infection) 07/2022 - 01/2019
5	Onchocerciasis 11/2021 - 04/2009
5	Filarial Elephantiasis (Lymphatic Filariasis) 03/2019 - 09/2010
4	Inflammation (Inflammations) 01/2022 - 01/2019
3	Coinfection 07/2022 - 12/2019
3	Sickle Cell Anemia (Hemoglobin S Disease) 01/2022 - 01/2020
3	Buruli Ulcer 06/2019 - 01/2018
2	Schistosomiasis (Bilharziasis) 06/2022 - 10/2006
2	COVID-19 04/2022 - 01/2021
2	Sickle Cell Trait 01/2022 - 01/2020
2	Neoplasms (Cancer) 12/2021 - 01/2020
2	Hemorrhage 12/2020 - 01/2017
2	Quebec platelet disorder 12/2020 - 01/2017
2	Parasitemia 01/2020 - 12/2019
2	Atherosclerosis 01/2019 - 01/2017
2	Falciparum Malaria (Plasmodium falciparum Malaria) 01/2017 - 01/2011
2	Hypersensitivity (Allergy) 01/2016 - 04/2008
1	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 07/2022
1	Child Nutrition Disorders 07/2022
1	Hyperglycemia 02/2022
1	Diabetes Mellitus 02/2022
1	Congenital Structural Myopathies (Centronuclear Myopathy) 01/2022
1	Persistent Infection 01/2022
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 12/2021
1	Autism Spectrum Disorder 09/2021
1	Heart Diseases (Heart Disease) 01/2021
1	Cytokine Release Syndrome 01/2021
1	Osteosarcoma (Osteogenic Sarcoma) 01/2020
1	Retinal Dystrophies 01/2020
1	Hemoglobinopathies 01/2020
1	Carcinogenesis 01/2020
1	Virus Diseases (Viral Diseases) 10/2019
1	Parasitic Diseases (Parasitic Disease) 01/2019
1	Wounds and Injuries (Trauma) 01/2019

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 07/2022 - 01/2017
5	Proteins (Proteins, Gene)FDA Link 07/2022 - 01/2019
5	Albendazole (Albenza)FDA Link 07/2022 - 10/2006
5	Pharmaceutical PreparationsIBA 06/2022 - 10/2011
5	Ivermectin (Mectizan)FDA Link 11/2017 - 04/2009
4	AntigensIBA 07/2022 - 10/2015
4	Hemoglobins (Hemoglobin)IBA 01/2022 - 08/2005
4	Messenger RNA (mRNA)IBA 12/2021 - 04/2008
4	CytokinesIBA 01/2021 - 12/2013
4	artemisinin (artemisinine)IBA 01/2021 - 01/2011
3	Indicators and Reagents (Reagents)IBA 07/2022 - 01/2016
3	Transcription Factors (Transcription Factor)IBA 01/2021 - 01/2016
2	Angiopoietin-1IBA 07/2022 - 04/2022
2	VaccinesIBA 07/2022 - 09/2012
2	Immunoglobulin G (IgG)IBA 07/2022 - 04/2021
2	Immunoglobulin E (IgE)IBA 07/2022 - 07/2022
2	MicroRNAs (MicroRNA)IBA 04/2022 - 01/2022
2	Sickle HemoglobinIBA 01/2022 - 01/2020
2	hemoglobin AAIBA 01/2022 - 09/2021
2	Biological ProductsIBA 11/2021 - 01/2018
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 12/2020 - 01/2017
2	lipoprotein-associated coagulation inhibitor (TFPI)IBA 12/2020 - 01/2017
2	Plasminogen Activators (Plasminogen Activator)IBA 12/2020 - 01/2017
2	ChromatinIBA 01/2020 - 01/2017
2	EnzymesIBA 11/2017 - 01/2017
2	Chloroquine (Aralen)FDA LinkGeneric 07/2011 - 02/2007
1	Angiopoietin-2IBA 07/2022
1	Chemokine CXCL10IBA 07/2022
1	ChemokinesIBA 07/2022
1	alpha-Glucosidases (Acid Maltase)IBA 02/2022
1	Blood Glucose (Blood Sugar)IBA 02/2022
1	Insulin (Novolin)FDA Link 02/2022
1	Plant ExtractsIBA 02/2022
1	benzimidazoleIBA 01/2022
1	TubulinIBA 01/2022
1	Valproic Acid (Depakote)FDA LinkGeneric 01/2022
1	FilaricidesIBA 11/2021
1	NucleotidesIBA 09/2021
1	AnthelminticsIBA 04/2021
1	Malaria VaccinesIBA 04/2021
1	p38 Mitogen-Activated Protein KinasesIBA 01/2021
1	Factor V (Coagulation Factor V)IBA 12/2020
1	Fibrinolysin FDA Link 12/2020
1	Thrombin FDA Link 12/2020
1	Interleukin-8 (Interleukin 8)IBA 01/2020
1	Retinaldehyde (Retinal)IBA 01/2020
1	Antimalarials (Antimalarial Agents)IBA 01/2020
1	Glutamic Acid (Glutamate)FDA Link 01/2020
1	Valine (L-Valine)FDA Link 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	beta-Globins (beta Globin)IBA 01/2020
1	Oxytocin Receptors (Oxytocin Receptor)IBA 01/2020
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2020
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2020
1	IronIBA 06/2019
1	trizolIBA 03/2019
1	Long Noncoding RNAIBA 01/2019
1	mycolactone AIBA 01/2019
1	Serotonin (5 Hydroxytryptamine)IBA 01/2019
1	Eosinophil Cationic ProteinIBA 01/2019
1	FrataxinIBA 01/2018

Therapy/Procedure

7	Therapeutics 04/2022 - 01/2011
7	Mass Drug Administration 01/2022 - 04/2009
1	Extracorporeal Membrane Oxygenation 12/2021